Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Reduction of prostate-specific antigen after tamsulosin treatment in patients with elevated prostate-specific antigen and lower urinary tract symptoms associated with low incidence of prostate cancer at biopsy.

Tubaro A, De Nunzio C, Mariani S, Trucchi A, Miano R, Vicentini C, Miano L.

Urology. 2010 Aug;76(2):436-41. doi: 10.1016/j.urology.2009.12.083. Epub 2010 Jun 9.

PMID:
20538320
3.
4.

Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.

Roehrborn CG, Kaplan SA, Kraus SR, Wang JT, Bavendam T, Guan Z.

Urology. 2008 Nov;72(5):1061-7; discussion 1067. doi: 10.1016/j.urology.2008.06.067. Epub 2008 Sep 25.

PMID:
18817961
5.

Can effect of finasteride on prostate-specific antigen be used to decrease repeat prostate biopsy?

Handel LN, Agarwal S, Schiff SF, Kelty PJ, Cohen SI.

Urology. 2006 Dec;68(6):1220-3. Epub 2006 Dec 4.

PMID:
17141826
6.

Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.

Magri V, Trinchieri A, Montanari E, Del Nero A, Mangiarotti B, Zirpoli P, de Eguileor M, Marras E, Ceriani I, Vral A, Perletti G.

Arch Ital Urol Androl. 2007 Jun;79(2):84-92.

PMID:
17695414
7.

Prostate specific antigen density of the transition zone for early detection of prostate cancer.

Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC, Marberger M.

J Urol. 1998 Aug;160(2):411-8; discussion 418-9.

PMID:
9679889
8.
9.

Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.

Schmid HP, Ravery V, Billebaud T, Toublanc M, Boccon-Gibod LA, Hermieu JF, Delmas V, Boccon-Gibod L.

Urology. 1996 May;47(5):699-703.

PMID:
8650868
10.
11.
12.

An assessment of the usefulness of serum prostate-specific antigen level and cancer volume in biopsy specimens to predict the extent of prostate cancer.

Gohji K, Nomi M, Kizaki T, Morisue K, Okamoto M, Takenaka A, Fujii A.

Br J Urol. 1997 Apr;79(4):602-7.

PMID:
9126092
13.

The role of free prostate-specific antigen in the diagnosis of prostate cancer.

Akdas A, Cevik I, Tarcan T, Turkeri L, Dalaman G, Emerk K.

Br J Urol. 1997 Jun;79(6):920-3.

PMID:
9202560
14.

High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: the clinician's dilemma.

Kehinde EO, Sheikh M, Mojimoniyi OA, Francis I, Anim JT, Nkansa-Dwamena D, Al-Awadi KA.

BJU Int. 2003 May;91(7):618-22.

15.

[Can indexes based on PSA determine which patients should undergo repeated ultrasound-guided transrectal prostatic biopsy? Study on 546 patients who underwent repeated biopsy].

Rodríguez-Patrón Rodríguez R, Mayayo Dehesa T, González Galán A, Zuccarino AL, García González R, Cuesta Roca C.

Arch Esp Urol. 2002 Dec;55(10):225-34. Spanish.

PMID:
12611220
16.
17.
18.

Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis.

van Iersel MP, Witjes WP, de la Rosette JJ, Oosterhof GO.

Br J Urol. 1995 Jul;76(1):47-53.

PMID:
7544204
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk